Seronegative and seropositive RA: alike but different?

ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial

(2014) Seth D Seegobin et al.   ARTHRITIS RESEARCH & THERAPY

Should We Redefine Treatment Targets in Rheumatoid Arthritis? Low Disease Activity Is Sufficiently Strict for Patients Who Are Anticitrullinated Protein Antibody-negative

(2013) Y. M. R. de Punder et al.   JOURNAL OF RHEUMATOLOGY

Autoimmunity in rheumatoid arthritis: different antigens—common principles

(2012) L A Trouw et al.   ANNALS OF THE RHEUMATIC DISEASES

Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study)

(2012) Kirsten Wevers-de Boer et al.   ANNALS OF THE RHEUMATIC DISEASES

The influence of ACPA status and characteristics on the course of RA

(2012) Annemiek Willemze et al.   Nature Reviews Rheumatology

Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies

(2012) D. van der Woude et al.   RHEUMATOLOGY

The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study

(2011) M van den Broek et al.   ANNALS OF THE RHEUMATIC DISEASES

Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage

(2011) J. Shi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?

(2011) Diederik PC De Rooy et al.   ARTHRITIS RESEARCH & THERAPY